Simple, Elegant Solutions for
Complex Clinical Challenges

QIAGEN’s innovative clinical platform, the Modaplex System, represents the next generation of quantitative PCR. Modaplex combines two established technologies—PCR® and capillary electrophoresis—to deliver highly multiplexed, quantitative clinical solutions.  

Our clinical research customers can use the Modaplex System as an open platform and immediately put it to work in their labs. And our pharmaceutical partners can collaborate with us to develop high-value companion diagnostic products.

With the Modaplex System, our customers can easily design very complex multi-modal assays that test for disparate target types like SNPs, expression biomarkers, miRNAs and fusion genes.  

QIAGEN’s technology is the next generation of quantitative PCR. 

Put the power of the Modaplex System to work for you. Contact us. 
Learn more about the Modaplex System.

The Modaplex System is a registered trademark. PCR® is a registered trademark of Roche Molecular Systems Inc.



There are no headline events to display.